Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.

Author Information

Stabellini G, Balducci C, Lilli C, Marinucci L, Becchetti E, Carinci F, Calastrini C, Dolci C, Lumare E, Locci P.

Department of Human Morphology, State University of Milan, Via Mangiagalli 31, 20133 Milan, Italy.

Publication